StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q/A on Nov 19, 2026Score 11/3058% below fair value
$13.16−0.06 (-0.45%)

Close on Nov 19, 2026Market cap $243.15MP/E –Yield –

USANA Health Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

USANA Health Sciences's free cash flow for the twelve months ending Oct 3, 2026 was $29.54M, up 58.0% year over year. For fiscal 2025 it was $8.53M, down 83.3% from the year before. Over ten years it grew -20.8% a year on average. The highest annual figure on record is $145.31M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Jan 3, 2026$8.53M-83.3%
FY2024Dec 28, 2024$50.92M-9.3%
FY2023Dec 30, 2023$56.15M-40.0%
FY2022Dec 31, 2022$93.50M-13.8%
FY2021Jan 1, 2022$108.46M-25.4%
FY2020Jan 2, 2021$145.31M+31.9%
FY2019Dec 28, 2019$110.16M-21.7%
FY2018Dec 29, 2018$140.69M+27.3%
FY2017Dec 30, 2017$110.55M+6.1%
FY2016Dec 31, 2016$104.19M+18.8%
FY2015Jan 2, 2016$87.74M+3.5%
FY2014Jan 3, 2015$84.76M-6.7%
FY2013Dec 28, 2013$90.84M+7.7%
FY2012Dec 29, 2012$84.37M+41.9%
FY2011Dec 31, 2011$59.47M-4.0%
FY2010Jan 1, 2011$61.92M+118.5%
FY2009Jan 2, 2010$28.34M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Oct 3, 2026$8.44M–
Q2 FY2026Jul 4, 2026$20.16M+180.4%
Q1 FY2026Apr 4, 2026$7.11M-43.9%
Q4 FY2025Jan 3, 2026-$6.19M-255.3%
Q3 FY2025Sep 27, 2025-$5.16M-119.0%
Q2 FY2025Jun 28, 2025$7.19M+35.2%
Q1 FY2025Mar 29, 2025$12.68M-12.4%
Q4 FY2024Dec 28, 2024$3.98M-78.7%
Q3 FY2024Sep 28, 2024$27.14M+30.6%
Q2 FY2024Jun 29, 2024$5.32M-10.5%
Q1 FY2024Mar 30, 2024$14.48M+35.0%
Q4 FY2023Dec 30, 2023$18.70M-49.7%
Q3 FY2023Sep 30, 2023$20.78M-18.7%
Q2 FY2023Jul 1, 2023$5.94M-53.8%
Q1 FY2023Apr 1, 2023$10.73M-40.1%
Q4 FY2022Dec 31, 2022$37.18M+70.8%
Q3 FY2022Oct 1, 2022$25.55M-17.7%
Q2 FY2022Jul 2, 2022$12.87M-65.8%
Q1 FY2022Apr 2, 2022$17.91M-0.8%
Q4 FY2021Jan 1, 2022$21.77M-53.1%
Q3 FY2021Oct 2, 2021$31.02M-33.0%
Q2 FY2021Jul 3, 2021$37.61M+29.3%
Q1 FY2021Apr 3, 2021$18.06M-23.2%
Q4 FY2020Jan 2, 2021$46.43M-8.1%
Q3 FY2020Sep 26, 2020$46.27M+0.4%
Q2 FY2020Jun 27, 2020$29.08M+174.2%
Q1 FY2020Mar 28, 2020$23.52M+698.9%
Q4 FY2019Dec 28, 2019$50.54M+33.5%
Q3 FY2019Sep 28, 2019$46.07M-11.9%
Q2 FY2019Jun 29, 2019$10.61M-68.8%
Q1 FY2019Mar 30, 2019$2.94M-82.2%
Q4 FY2018Dec 29, 2018$37.86M-25.9%
Q3 FY2018Sep 29, 2018$52.27M+382.3%
Q2 FY2018Jun 30, 2018$33.99M-32.2%
Q1 FY2018Mar 31, 2018$16.57M–
Q4 FY2017Dec 30, 2017$51.08M+5.3%
Q3 FY2017Sep 30, 2017$10.84M–
Q2 FY2017Jul 1, 2017$50.12M–
Q1 FY2017Apr 1, 2017-$1.48M–
Q4 FY2016Dec 31, 2016$48.50M–

More USANA Health Sciences figures

See a number that looks wrong?